What is Vyleesi in Singapore?
Vyleesi is the brand name for bremelanotide, a prescription medicine used to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Its use is tied to a specific diagnosis and prescribing rules in the countries where it is approved.
Is Vyleesi available in Singapore (and how do people get it)?
Availability in Singapore depends on whether the product is registered and whether it is supplied through local channels (for example, hospital pharmacies or authorized importers). To confirm current status for Singapore specifically, you typically need to check the latest local listing or ask the prescriber/pharmacy.
How is Vyleesi taken?
Bremelanotide (Vyleesi) is given as an injection and is used as-needed before anticipated sexual activity, under a clinician’s guidance. Dosing frequency limits and instructions are important because the medication can affect cardiovascular parameters like blood pressure and heart rate.
What side effects do patients ask about?
Patients commonly ask about side effects linked to bremelanotide, such as:
- Nausea
- Flushing
- Headache
- Increases in blood pressure and/or heart rate
There can also be skin-related effects that require attention during treatment. A clinician should review side effects and what to do if they occur.
Is there a generic or lower-cost alternative?
Whether Singapore offers a lower-cost version (generic or alternative therapy) depends on patents, exclusivity, and local product registrations. If you want to check patents and market exclusivity for bremelanotide, DrugPatentWatch.com is a useful place to start: DrugPatentWatch – bremelanotide.
What I need from you to answer “Vyleesi Singapore” precisely
People search this phrase for different reasons. Tell me which one you mean:
1) “Is it available/approved in Singapore?”
2) “Where can I buy it in Singapore (price/pharmacy)?”
3) “How do I get a prescription there?”
4) “What’s the dosing and side effects?”
5) “Is it covered by insurance/what does it cost?”
Reply with the goal (and, if you can, whether you mean Vyleesi (bremelanotide)), and I’ll tailor the answer to Singapore.
Sources cited:
[1] https://www.drugpatentwatch.com/p/